Sharon Nessim, McGill University

Research

Biomarkers Canagliflozin Peritoneal Dialysis Peritoneal Equilibration Test Peritoneal Fibrosis Randomized Crossover Study Ultrafiltration Failure Solute Clearance

Latest papers

Variation in the level of eGFR at dialysis initiation across dialysis facilities and geographic regions.
Clinical journal of the American Society of Nephrology : CJASN · 2014
Longitudinal study of renal function in systemic sclerosis.
Journal of Rheumatology · 2012
Papillary thyroid carcinoma associated with amyloid goiter.
Thyroid : official journal of the American Thyroid Association · 2005 · first author

All 3 publications

Latest funding

Impact of Canagliflozin on peritoneal membrane function and integrity in patients with kidney failure on Peritoneal Dialysis
CIHR · 2026 · Principal investigator
$187,424
Effect of Canagliflozin on Peritoneal Function and Fibrosis in Patients on Peritoneal Dialysis: a proof-of-concept randomized crossover clinical trial (CAN-PD trial).
CIHR · 2024 · Principal investigator
$100,000
Aldosterone antagonism and enhanced Clearance for Health Improvement EValuation in End-stage renal disease (ACHIEVE) Trial
CIHR · 2016 · Co-investigator
$2,652,816

All 5 grants and awards

3 publications.

01

Variation in the level of eGFR at dialysis initiation across dialysis facilities and geographic regions.

Sood MM, Manns B, Dart A, Hiebert B, Kappel J, Komenda P, Molzahn A, Naimark D, Nessim S, Rigatto C, Soroka S, Zappitelli M, Tangri N, Canadian Kidney Knowledge Translation and Generation Network (CANN-NET)

Clinical journal of the American Society of Nephrology : CJASN2014

DOI: 10.2215/cjn.12321213 PMID: 25248743

02

Longitudinal study of renal function in systemic sclerosis.

Caron M, Hudson M, Baron M, Nessim S, Steele R

Journal of Rheumatology201224 citations

DOI: 10.3899/jrheum.111417

03

Papillary thyroid carcinoma associated with amyloid goiter.

Nessim S, Tamilia M

Thyroid : official journal of the American Thyroid Association2005First author

DOI: 10.1089/thy.2005.15.382 PMID: 15876164

Impact of Canagliflozin on peritoneal membrane function and integrity in patients with kidney failure on Peritoneal Dialysis

Principal investigatorCIHR2026Project Grant

Principal investigators: Mavrakanas, Thomas; Nadeau-Fredette, Annie-Claire; Nessim, Sharon J; Trinh, Emilie

Keywords: Biomarkers; Canagliflozin; Peritoneal Dialysis; Peritoneal Equilibration Test; Peritoneal Fibrosis; Randomized Crossover Study; Solute Clearance; Ultrafiltration Failure

$187,424

Effect of Canagliflozin on Peritoneal Function and Fibrosis in Patients on Peritoneal Dialysis: a proof-of-concept randomized crossover clinical trial (CAN-PD trial).

Principal investigatorCIHR2024Project Grant - PA: Nutrition, Metabolism and Diabetes

Principal investigators: Mavrakanas, Thomas; Nadeau-Fredette, Annie-Claire; Nessim, Sharon J; Trinh, Emilie

Keywords: Biomarkers; Canagliflozin; Peritoneal Dialysis; Peritoneal Equilibration Test; Peritoneal Fibrosis; Randomized Crossover Study; Ultrafiltration Failure

$100,000

Aldosterone antagonism and enhanced Clearance for Health Improvement EValuation in End-stage renal disease (ACHIEVE) Trial

Co-investigatorCIHR2016Project Grant

Principal investigators: Walsh, Michael W

Keywords: Aldosterone; Dialysis; End-Stage Renal Disease; Heart Failure; Hemodialysis; Mineralocorticoid Receptor Antagonist; Spironolactone; Sudden Death; Uremia

$2,652,816

Protection of the heart with aldosterone antagonism in end-stage renal disease (PHASE 2) Trial

Co-investigatorCIHR2014Operating Grant - PA: INMD Start-up Funds (Clinicians and New Investigators)

Principal investigators: Walsh, Michael W; Devereaux, Philip J; Wald, Ron

Keywords: Aldosterone; End-Stage Renal Disease; Hemodialysis; Randomized Controlled Trial; Spironolactone

$100,000

The Peritoneal Dialysis Outcomes and Practice Patterns Study (P-DOPPS)

Co-investigatorCIHR2013Operating Grant: Industry-partnered Collaborative Research

Principal investigators: Perl, Jeffrey

Keywords: Collaboration; Hospitalization; Peritoneal Dialysis; Peritoneal Dialysis Treatment Time; Pratice Patterns; Prospective Observational Cohort Study; Quality Of Life; Survival

$500,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Internal Medicine
Medicine
Medicine/Nephrology
Medicine/Endocrinology/Metabolism
Psychiatry
Rheumatology
Mathematics and Statistics
Other

Applying for

Paper to mentionMention their CIHR grant from 2026

Subject: Prospective PhD student: Biomarkers Dear Professor Nessim, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Variation in the level of eGFR at dialysis initiation across dialysis facilities and geographic regions." (2014), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Impact of Canagliflozin on peritoneal membrane function and integrity in patients with kidney failure on Peritoneal Dialysis" (2026), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]